While flu and RSV cases are at yearly lows in the U.S., COVID-19 infections remain high, with an estimated 250,000 daily cases. If you're experiencing illness, COVID-19 is a likely culprit. We are seeing a new surge of KP.3 sub-variants and the LB.1 variant. These variants are sending people to the hospital at an increasing rate. In the U.S., hospitalizations have increased by 25% in a week, and sadly, deaths are up by 16% over the prior week.
Hi TACT...I thought you might find the linked paper of interest. This research is consistent with the content above, quoting the research that "...the reduced infection risk associated with anti-S antibody levels was limited."
You're writing as if natural infection and vaccines give the same level of protection. They don't. Since Omicron, natural infection can dampen the immune response to the spike protein. So even if someone is infected with KP.3 over the summer, a booster could still be beneficial in the fall. We need better vaccines, but we also need to be responsible with messaging about our current options.
Hi TACT...I thought you might find the linked paper of interest. This research is consistent with the content above, quoting the research that "...the reduced infection risk associated with anti-S antibody levels was limited."
https://www.medrxiv.org/content/10.1101/2024.06.05.24308479v1
You're writing as if natural infection and vaccines give the same level of protection. They don't. Since Omicron, natural infection can dampen the immune response to the spike protein. So even if someone is infected with KP.3 over the summer, a booster could still be beneficial in the fall. We need better vaccines, but we also need to be responsible with messaging about our current options.
https://www.imperial.ac.uk/news/237315/omicron-infection-poor-booster-covid-19-immunity/?fbclid=IwZXh0bgNhZW0CMTEAAR3DwYfxo1eyXqm0Za54E31d0RTqpCVSbUDrK6O3S71owqKbfz5HPNAVzg4_aem_UexfwPE6ReRzraLhtLo3TQ
https://www.mountsinai.org/about/newsroom/2024/longterm-data-reveals-sarscov2-infection-and-vaccineinduced-antibody-responses-are-longlasting